Evidence map›Paper›PMID 39054376›Full record

ReviewNature reviews. Cardiology2024

Epidemiology of cardiometabolic health in Latin America and strategies to address disparities.

Luisa C C Brant, J Jaime Miranda, Rodrigo M Carrillo-Larco, David Flood, Vilma Irazola, Antonio Luiz P Ribeiro

Abstract readReview
In one paragraph

Review in Nature reviews. Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Steatotic liver disease in Latin America: current views and perspectives.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  3. Article
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Neural embedding of frailty in cognitively unimpaired aging and dementia across Latin America.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Luisa C C BrantFaculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. luisabrant@gmail.com.ORCID 0000-0002-7317-1367
J Jaime MirandaSydney School of Public Health, Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.ORCID 0000-0002-4738-5468
Rodrigo M Carrillo-LarcoHubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
David FloodDepartment of Medicine, University of Michigan, Ann Arbor, MI, USA.
Vilma IrazolaCenter of Excellence for Cardiovascular Health, Department of Research in Chronic Diseases, Institute for Clinical Effectiveness and Health Policy, Buenos Aires, Argentina.
Antonio Luiz P RibeiroFaculty of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.ORCID 0000-0002-2740-0042

Funding

Household Air Pollution and Health: A Multi-Country LPG Intervention TrialUM1HL134590 · NHLBI · EMORY UNIVERSITY · PI CHECKLEY, WILLIAM, CLASEN, THOMAS F · 2016 to 2021
$31.1M
PRIMECare Trial: Preventing Ischemic Heart Disease with mHealth, electronic decision support, and Community Health Workers.R01HL149912 · NHLBI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI GAZIANO, THOMAS A · 2020 to 2024
$3.2M
Latin America Treatment & Innovation Network in Mental Health (LATIN-MH)U19MH098780 · NIMH · FUNDACAO FACULDADE DE MEDICINA · PI ARAYA, RICARDO, MENEZES, PAULO ROSSI · 2013 to 2017
$2.7M
Comprehensive Approach for Hypertension Prevention and Control in ArgentinaU01HL114197 · NHLBI · TULANE UNIVERSITY OF LOUISIANA · PI HE, JIANG · 2012 to 2016
$2.0M
Launching a salt substitute to reduce blood pressure at the population level-PeruU01HL114180 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI GILMAN, ROBERT H · 2012 to 2016
$2.0M
Implementing a Multicomponent Intervention to Improve Hypertension Control in Central AmericaU01HL138647 · NHLBI · INSTITUTE/NUTRITION/CENT/AMERICA/PANAMA · PI HE, JIANG, RAMIREZ-ZEA, MANUEL · 2017 to 2021
$1.6M
Implementation research for comprehensive cardiometabolic care in GuatemalaK23HL161271 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Clifford Flood · 2022 to 2026
$949k
Promoting Capacity Building in Chronic Diseases Research in South AmericaD43TW009126 · FIC · INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT · PI IRAZOLA, VILMA · 2012 to 2016
$949k
REACH-Es: Adapting a digital health tool to improve diabetes medication adherence among Latino adultsK23DK135798 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Jacqueline Anne Seiglie · 2023 to 2026
$784k
Application of novel biomarkers to measure health impacts of anthropogenic change in the AmazonK01TW011478 · FIC · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI FEINGOLD, BETH · 2020 to 2023
$641k
Building sustainable and innovative research in Cancer and Cardiovascular disease: Planning the design and development of the South American Center of Research Excellence to Counter NCDs (SACREN)P20CA217231 · NCI · INSTITUTO DE EFECTIVIDAD CLINICA Y SANIT · PI IRAZOLA, VILMA · 2017 to 2018
$497k
MHealth interventions to improve access and coverage of uninsured people with high cardiovascular risk in ArgentinaR21TW010173 · FIC · BRIGHAM AND WOMEN'S HOSPITAL · PI GAZIANO, THOMAS A · 2016 to 2017
$342k
FIC NIH HHS D43 TW009126FIC NIH HHS D71 TW010877FIC NIH HHS K01 TW011478FIC NIH HHS R21 TW009982FIC NIH HHS R21 TW010173FIC NIH HHS R21 TW011740Medical Research Council MR/X004163/1NCI NIH HHS P20 CA217231NHLBI NIH HHS HHSN268200900028CNHLBI NIH HHS HHSN268200900033CNHLBI NIH HHS K23 HL161271NHLBI NIH HHS R01 HL149912NHLBI NIH HHS U01 HL114180NHLBI NIH HHS U01 HL114197NHLBI NIH HHS U01 HL138647NHLBI NIH HHS UM1 HL134590NIDDK NIH HHS K23 DK135798NIMH NIH HHS U19 MH098780Wellcome Trust
6 · The paper itself

Abstract

In Latin America and the Caribbean (LAC), sociodemographic context, socioeconomic disparities and the high level of urbanization provide a unique entry point to reflect on the burden of cardiometabolic disease in the region. Cardiovascular diseases are the main cause of death in LAC, precipitated by population growth and ageing together with a rapid increase in the prevalence of cardiometabolic risk factors, predominantly obesity and diabetes mellitus, over the past four decades. Strategies to address this growing cardiometabolic burden include both population-wide and individual-based initiatives tailored to the specific challenges faced by different LAC countries, which are heterogeneous. The implementation of public policies to reduce smoking and health system approaches to control hypertension are examples of scalable strategies. The challenges faced by LAC are also opportunities to foster innovative approaches to combat the high burden of cardiometabolic diseases such as implementing digital health interventions and team-based initiatives. This Review provides a summary of trends in the epidemiology of cardiometabolic diseases and their risk factors in LAC as well as context-specific disease determinants and potential solutions to improve cardiometabolic health in the region.

Indexed as

Cardiovascular DiseasesCardiometabolic Risk FactorsHealthcare DisparitiesHealth Status DisparitiesHumansLatin AmericaPrevalenceRisk FactorsSocioeconomic Factors

Identifiers

PMID39054376
PMCPMC12065570

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.